About BioVinc:visit here
BioVinc, LLC is a privately owned R&D company based in Los Angeles area, California. BioVinc
offers new fluorescent molecular probes that target bone, based on technology developedxessay
by Professor Charles E. McKenna at the University of Southern California. The probes are
derived from nitrogen-containing bisphosphonates such as risedronate (RIS) and zoledronate
(ZOL), including lower affinity analogues, conjugated with a wide choice of popular visible and
near infrared fluorescent dyes to address different imaging needs. Custom “mix-and-match”
bisphosphonate-dye pairings are also available on request.
The BioVinc team includes world-leading scientists on bisphosphonate chemistry,
microscopy, and pharmacology related to bone and bone diseases, whose expertise is
at the disposal of our customers. The probes have been used in diverse imaging studies
including research on bone metabolism, cancer, and dental conditions. By providing both
off-the-shelf imaging probes and individually tailored probe design services, BioVinc can
help with all aspects of your research needs.
BioVinc LLC is a small biotech that also has an extraordinary portfolio of IP and development
products which collectively address a product market of over $1-2 billion per year. The portfolio
is based on its core expertise in bisphosphonate research that has led to a platform technology to
leverage selective bone targeting properties. New small molecule leads have been developed toward
a Preventative Therapy for Osteonecrosis of the Jaw in oral surgery patients; Bone selective antibiotics
for Infectious Bone Disease. Other advances are underway towards re-Purposed Drugs for Rheumatoid
Arthritis, Osteoporosis, and bone cancers; and Optical and Nuclear Diagnostic Imaging Probes, including
a superior PET scan technology for the replacement of Technetium imaging.